YY/T 1224-2014
Detection kit for analysis of related chromosome and gene abnormalities in bladder cancer (Fluorescent in situ hybridization) (English Version)
- Standard No.
- YY/T 1224-2014
- Language
- Chinese, Available in English version
- Release Date
- 2014
- Published By
- Professional Standard - Medicine
- Latest
- YY/T 1224-2014
- Scope
- This standard specifies the definition, composition, requirements, test methods, identification, labels, instructions for use, packaging, transportation and storage of bladder cancer cell-related chromosome and gene abnormality detection kits (fluorescence in situ hybridization). This standard is applicable to the detection of Nos. 3, 7, and 17 on samples (usually urine exfoliated cell smears) composed of four fluorescent in situ hybridization probes and counterstains at the corresponding sites of CSP3, CSP7, CSP17, and GLP9. Increased aneuploidy on chromosome 9 and deletion of the P16 gene locus on chromosome 9, thereby assisting in the diagnosis of bladder cancer. This standard does not apply to: a) kits based on immunohistochemical staining diagnostic methods for auxiliary diagnosis of bladder cancer; b) kits based on enzyme-linked immunosorbent assay and other labeled immunoassays for auxiliary diagnosis of bladder cancer Diagnostic kits.
YY/T 1224-2014 history
- 2014 YY/T 1224-2014 Detection kit for analysis of related chromosome and gene abnormalities in bladder cancer (Fluorescent in situ hybridization)
